Utilizing Solid-State Techniques and Accelerated Conditions to Understand Particle Size Instability in Inhaled Drug Substances.

Accelerated Stability Crystallization Dry Powder Inhaler Micronization Particle Size Fusion Respirable Size

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
08 2021
Historique:
received: 15 02 2021
revised: 07 05 2021
accepted: 07 05 2021
pubmed: 19 5 2021
medline: 5 8 2021
entrez: 18 5 2021
Statut: ppublish

Résumé

Micronization by air jet milling is often used to produce drug substance particles of acceptable respirable size for use in dry powder inhaler formulations. The energy from this process often induces surface disordered sites on the micronized particles with potential consequences for the long-term stability of the drug substance. In this study, two lots of the same drug substance were qualitatively determined to have different extents of disordered surface using dynamic vapor sorption and scanning electron microscopy. These differences led to observable divergences in particle size and morphology between lots of drug substances on long-term and accelerated stability. The studies investigate the contribution of temperature and humidity, morphology prior to milling, and stability behavior post-micronization. The results highlight the importance of controlling the crystallization solvents upstream of micronization and their contribution to a material's susceptibility to milling-induced disorder on long-term physical stability. Furthermore, this work proposes an accelerated technique useful in predicting stability behavior of micronized drug substances in days rather than months, especially in cases where small differences cannot be detected by standard solid-state techniques.

Identifiants

pubmed: 34004219
pii: S0022-3549(21)00250-1
doi: 10.1016/j.xphs.2021.05.006
pii:
doi:

Substances chimiques

Powders 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3037-3046

Informations de copyright

Copyright © 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of Competing Interest None.

Auteurs

Daniel P Dobson (DP)

Genentech, 1 DNA Way, South San Francisco, CA 94080, United States.

Evelyn Yanez (E)

Genentech, 1 DNA Way, South San Francisco, CA 94080, United States.

Joseph W Lubach (JW)

Genentech, 1 DNA Way, South San Francisco, CA 94080, United States.

Andreas Stumpf (A)

Genentech, 1 DNA Way, South San Francisco, CA 94080, United States.

Jackson Pellet (J)

Genentech, 1 DNA Way, South San Francisco, CA 94080, United States.

Jerry Tso (J)

Genentech, 1 DNA Way, South San Francisco, CA 94080, United States. Electronic address: tsoj@gene.com.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Biomass Lignin Wood Populus Microscopy, Electron, Scanning
Calcium Carbonate Sand Powders Construction Materials Materials Testing

Characterization of 3D printed composite for final dental restorations.

Lucas Eigi Borges Tanaka, Camila da Silva Rodrigues, Manassés Tércio Vieira Grangeiro et al.
1.00
Composite Resins Materials Testing Printing, Three-Dimensional Surface Properties Flexural Strength

Classifications MeSH